Multiple legacy products, including Revlimid (-56% YTD) and Pomalyst (-48% YTD), are experiencing severe revenue declines from generic competition. This creates immense pressure to accelerate growth in new products and optimize commercial operations to offset billions in lost sales.
Filing excerpt
Revlimid revenues decreased 49% during the second quarter of 2026 and 56% year-to-date, primarily due to lower demand in the U.S. as a result of generic erosion, partially offset by higher average net selling prices.
What this signalsFilings often name leadership changes, deals and spending plans.
Regions named
sec-10qmarketShareLossGet every 10-Q signal for Bristol Myers Squibb and the companies you sell to, in the tools you already use.
Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Bristol Myers Squibb this week?”
The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.
Sign up and spend your free credits on the companies you sell to.
This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.
Company
linkedin_urlValue in the APIindustriesValue in the APIemployee_count_lowValue in the APIemployee_count_highValue in the APIrevenueValue in the APIdescriptionValue in the APISignal
signal_nameValue in the APIassociationValue in the APIGET /v1/signals/6cc88022-c1ca-4758-9878-5d7827b5a021 returns this record as JSON. POST /v1/companies/enrich returns every signal for bms.com.
{
"signal_id": "6cc88022-c1ca-4758-9878-5d7827b5a021",
"signal_type": "sec-10q",
"signal_subtype": "marketShareLoss",
"detected_at": "2026-08-04T07:03:39.423+00:00",
"company": {
"name": "Bristol Myers Squibb",
"domain": "bms.com"
},
"data": {
"detail": "Multiple legacy products, including Revlimid (-56% YTD) and Pomalyst (-48% YTD), are experiencing severe revenue declines from generic competition. This creates immense pressure to accelerate growth in new products and optimize commercial operations to offset billions in lost sales.",
"metrics": {
"pct": -0.56,
"timeframe": "current_year",
"pct_context": "Revlimid YTD revenue decline"
},
"summary": "Legacy portfolio revenue plummets with Revlimid down 56% YTD due to generic erosion",
"excerpts": "Revlimid revenues decreased 49% during the second quarter of 2026 and 56% year-to-date, primarily due to lower demand in the U.S. as a result of generic erosion, partially offset by higher average net selling prices.",
"relevance": 0.9,
"sentiment": "negative",
"confidence": "high",
"source_url": "https://www.sec.gov/Archives/edgar/data/14272/000001427226000020/bmy-20260630.htm",
"filing_date": "2026-07-30",
"filing_year": 2026,
"fiscal_year": 0,
"fiscal_year_end": "06/30",
"sales_relevance": "Urgency to improve",
"signal_category": "market",
"regions_mentioned": [
"U.S.",
"EU",
"Japan"
]
}
}
curl https://signals.autobound.ai/v1/signals/6cc88022-c1ca-4758-9878-5d7827b5a021 \
-H "X-API-KEY: $AUTOBOUND_API_KEY"curl -X POST https://signals.autobound.ai/v1/companies/enrich \
-H "X-API-KEY: $AUTOBOUND_API_KEY" \
-H "Content-Type: application/json" \
-d '{"domain":"bms.com","limit":20}'Long text fields are shortened on this page.
Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.